Draig Therapeutics
Developing transformative, best-in-class neuropsychiatric therapies
$65MSeries B
Role not disclosedActivity from announced rounds
Developing transformative, best-in-class neuropsychiatric therapies
Develops therapies to halt fibrosis in multiple organ systems